Paclitaxel and mitoxantrone in metastatic breast cancer: A phase II trial of the Italian Oncology Group for Cancer Research

Cancer Investigation

Volumn 22, Issue 3, 2004, Pages 331-337

  Di Costanzo, Francesco ^a   Manzione, Luigi ^b   Gasperoni, Silvia ^a   Bilancia, Domenico ^b   Acito, Luigi ^c   Angiona, Sabrina ^a   Mazzoni, Francesca ^a   Giustini, Lucio ^c  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b SAN CARLO HOSPITAL   (Italy)

^c General Hospital A Murri   (Italy)

Author keywords

Anthracyclines; Metastatic breast cancer (MBC); Mitoxantrone; Paclitaxel

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; METHYLPREDNISOLONE; MITOXANTRONE; ORPHENADRINE; PACLITAXEL; PREDNISONE; RANITIDINE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; FEMALE; FEVER; HUMAN; ITALY; LEUKOPENIA; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PLEURA METASTASIS; PRIORITY JOURNAL; SKIN METASTASIS; SOFT TISSUE METASTASIS; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARDIOMYOPATHIES; CHEMOTHERAPY, ADJUVANT; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MIDDLE AGED; MITOXANTRONE; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 4744364188     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200029054     Document Type: Article

References (31)

1. Fossati, R.; Confalonieri, C.; Toni, V.; Ghislandi, E.; Penna, A.; Pistotti, V.; Tinazzi, A.; Liberati, A. Cytotoxic and hormonal treatment for metastatic breast cancer: a systemic review of publisher randomized trials involving 31,510 women. J. Clin. Cancer 1998, 16, 3439-3460.
2. Harris, J.R.; Lippman, M.E.; Veronesi, U.; Willett, W. Medical progress: breast cancer. N. Engl. J. Med. 1992, 327 (7), 473-480.
3. Rowinsky, E.K.; Cazenave, L.A.; Donehower, R.C. Taxol a novel investigational antimicrotubule agent. J. Natl. Cancer Inst. 1990, 82, 1247-1259.
4. Rowinsky, E.K.; Donehower, R.C. The clinical pharmacology of Paclitaxel (Taxol). Semin. Oncol. 1993, 20, 16-25.
5. Holmes, F.A.; Walters, R.S.; Theriault, R.L. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 1991, 83, 1797-1805.
6. Gianni, L.; Capri, G.; Munzone, E.; Straneo, M. Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines. Semin. Oncol. 1994, 21 (suppl 8), 29-33.
7. Abrams, J.S.; Vena, D.A.; Baltz, J.; Adams, J.; Montello, M.; Christian, M.; Onetto, N.; Desmond-Hellmann, S.; Canetta, R.; Friedman, M.A.; Arbuk, S.G. Paclitaxel activity in heavily pre-treated breast cancer: a national cancer institute treatment referral center trial. J. Clin. Oncol. 1995, 13, 2056-2065.
8. Wilson, W.H.; Berg, S.L.; Bryant, G.; Wittes, R.E.; Bates, S.; Fojo, A.; Steinberg, S.M.; Goldspiel, B.R.; Herdt, J.; O'Shaughnessy, J.; Balis, P.M.; Chabner, B.A. Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J. Clin. Oncol. 1994, 12, 1621-1629.
9. Eisenhauer, E.A.; Bokkel Huinink, W.W.; Swenerton, K.D.; Gianni, L.; Myles, J.; Van de Burg, M.E.L.; Kerr, I.; Vermoken, J.B.; Buser, K.; Colombo, N.; Bacon, M.; Santabàrbara, P.; Onetto, B.; Winograd, B.; Canetta, R. European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion. J. Clin. Oncol. 1994, 12, 2654-2666.
10. Nabholtz, J.M.; Gelmon, K.; Bontenbal, M.; Spielmann, M.; Catimel, G.; Conte, P.; Klaasen, U.; Namer, M.; Bonneterre, J.; Fumoleau, P.; Winograd, B. Multicenter, randomized comparative study of two doses of Paclitaxel in patients with metastatic breast cancer. J. Clin. Oncol. 1996, 14, 1858-1867.
11. Clemons, M.; Leahy, M.; Valle, J.; Jayson, G.; Ranson, M.; Howell, A. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes. Eur. J. Cancer 1997, 33, 2183-2193.
12. Gianni, L.; Munzone, E.; Capri, G.; Fulfaro, F.; Tarenzi, E.; Villani, F.; Spreafico, C.; Laffranchi, A.; Caraceni, A.; Martini, C.; Stefanelli, M.; Valagussa, P.; Bonadonna, G. Paclitaxel by 3 hour Infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose finding and sequence-finding study. J. Clin. Oncol. 1995, 13, 2688-2699.
13. Frassineti, G.L.; Zoli, W.; Silvestro, L.; Serra, P.; Milandri, C.; Tienghi, A.; Gianni, L.; Gentile, A.; Salzano, E.; Amadori, D. Paclitaxel plus Doxorubicin in breast cancer: an Italian experience. Semin. Oncol. 1997, 24 (suppl 17), 19-25.
14. Dombernowsky, P.; Boesgaard, M.; Andersen, E.; Jensen, B.V. Doxorubicin plus Paclitaxel in advanced breast cancer. Semin. Oncol. 1997, 24 (suppl 17), 15-18.
15. Hainsworth, J.D. The use of Mitoxantrone in the treatment of breast cancer. Semin. Oncol. 1995, 22 (suppl 1), 17-20.
16. Pavesi, L.; Preti, P.; Da Prada, G.; Pedrazoli, P.; Poggi, G.; Robustelli della Cuna, G. Epirubicin versus Mitoxantrone in combination chemotherapy for metastatic breast cancer. Anticancer Res. 1995, 75, 495-502.
17. Alonso, M.C.; Tabernero, J.M.; Ojeda, B.; Llanos, M.; Sola, C.; Climent, M.A.; Segui, M.A.; Lopez, J.J. A phase III randomized trial of cyclophosphamide, Mitoxantrone, and 5-Fluorouracil (CNF) versus Cyclophosphamide, Adriamycin, and 5-Fluorouracil (CAF) in patients with metastatic breast cancer. Breast Cancer Res. Treat. 1995, 34, 15-24.
18. Green, J.A.; Slater, A.J.; Campbell, I.R.; Kelly, V. Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with Cyclophosphamide and Vincristine. Breast Cancer Res. Treat. 1996, 39, 155-163.
19. Henderson, I.C.; Allegra, J.C.; Woodcock, T.; Wolff, S.; Bryan, S.; Catwright, K.; Dukart, G.; Henry, D. Randomized clinical trial comparing Mitoxantrone with Doxorubicin in previously treated patients with metastatic breast cancer. J. Clin. Oncol. 1989, 7, 560-571.
20. Shenkenberg, T.D.; Von Hoff, D.D. Mitoxantrone: a new anticancer drug with significant clinical activity. Ann. Intern. Med. 1986, 705, 67-81.
21. Di Costanzo, F.; Sdrobolini, A.; Manzione, L.; Bilancia, D.; Acito, L.; Gasperoni, S.; Valenti, L.; Fioriti, L.; Angiona, S.; Giustini, L. Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study. Breast Cancer Res. Treat. 1999, 54, 165-171.
22. WHO Handbook for Reporting Results of Cancer Treatment; WHO Offset Publication 48, World Health Organization: Geneva, Switzerland, 1979.
23. Hryniuk, W.M.; Figuredo, A.; Goodyear, M. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin. Oncol. 1987, 14 (suppl 4), 3-11.
24. Luck, H.J.; Thomssen, C.; DuBois, A. Interim analysis of a phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. Semin. Oncol. 1996, 23 (suppl 1), 33-36.
25. Paridaens, R. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey. Semin. Oncol. 1998, 25 (suppl 12), 3-6.
26. Pagani, O. Taxoids in combination with epirubicin: the search for improved outcomes in breast cancer. Semin. Oncol. 1998, 25 (suppl 12), 23-26.
27. Fleming, F.; Janisch, L.; Vogelzang, N.J.; Vokes, E.E.; Ratain, M.J. Phase I study of escalating doses of Mitoxantrone and Paclitaxel with granulocyte-macrophage colony stimulating factor support. Cancer 1996, 77, 2308-2312.
28. Panagos, G.E. Treatment of advanced and relapsing breast cancer with combination of Paclitaxel and Mitoxantrone. Semin. Oncol. 1997, 24 (suppl 3), 17-21.
29. Alexopoulos, A.; Kouroussis, C.; Malamos, N. Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as first-line chemotherapy in metastatic breast cancer: a multicenter phase II study. Ann. Oncol. 2001, 72 (6), 793-798.
30. Harvey, J.; Cantrell, J.J.; Campbell, M.; Cartmell, A.; Urba, W. Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancer. Cancer Investig. 2001, 19 (3), 225-233.
31. Greco, F.A.; Hainsworth, J.D. Paclitaxel with Mitoxantrone with or without 5-Fluorouracil, and high dose Leucovorin in the treatment of metastatic breast cancer. Semin. Oncol. 1997, 24 (suppl 17), 61-64.